Healthcare provider profile · identity verified

Ken Ye, MD

Allopathic & Osteopathic Physicians|Internal Medicine · MUSKEGON, MI · NPI 1427035229

Profile state: payments and partd Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

CMS Open Payments records show Ken Ye, MD received $18.85 in general payments during 2025 across 1 reported records.

Boehringer Ingelheim Pharmaceuticals, Inc. accounted for 100.0% of that reported general-payment amount.

The Open Payments records used for this analysis explicitly named 1 associated product.

A separate comparison found the same explicitly named product in public Medicare Part D data: Jardiance.

Boehringer Ingelheim Pharmaceuticals, Inc. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported JARDIANCE as an associated drug or biological on 123636 records involving 49438 distinct recipient NPIs. Public Medicare Part D data also shows 182 claims for Jardiance by this doctor in 2024.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

$18.85

1 reported records · 1 companies

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Who paid this doctor?

Companies in 2025 General Payments

Reported company	Canonical company	Amount	Share	Records	Year
Boehringer Ingelheim Pharmaceuticals, Inc.	Unresolved — no canonical attribution shown	$18.85	100.0%	1	2025

What were the payments for?

Payment categories

Category	Amount	Records
Education	$18.85	1

A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.

Analysis 1 · Payment-linked products

Products named in Open Payments records

Reported product	Type	Reported company	Related amount*	Records	Year
JARDIANCE Normalized: jardiance	Drug	Boehringer Ingelheim Pharmaceuticals, Inc.	$18.85	1	2025
Source payment records 2025-02-16 · Boehringer Ingelheim Pharmaceuticals, Inc. · $18.85 · Open Payments source

* Product-associated amounts are non-additive because one payment record may name more than one product.

These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.

Public prescribing for products named in payments

Open Payments product	Payment year	Part D brand	Part D year	Claims	Match method	Source
JARDIANCE jardiance	2025	Jardiance	2024	182	exact normalized	Medicare Part D

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

Paying company	Payment year	Drug reported by same entity	Open Payments evidence	Part D	Claims	Beneficiaries
Boehringer Ingelheim Pharmaceuticals, Inc. Exact reporting entity; no affiliate inference	2025	JARDIANCE open payments reported associated product	CMS Open Payments — General Payments 123636 supporting records · 49438 recipient NPIs · example record 1221811583	Jardiance · 2024 Exact normalized brand match · 1 Part D row	182	42

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	947	274
Amlodipine Besylate	Amlodipine Besylate	792	223
Losartan Potassium	Losartan Potassium	571	164
Rosuvastatin Calcium	Rosuvastatin Calcium	571	168
Omeprazole	Omeprazole	502	161
Carvedilol	Carvedilol	443	128
Lisinopril	Lisinopril	443	125
Levothyroxine Sodium	Levothyroxine Sodium	424	116
Metoprolol Succinate	Metoprolol Succinate	418	124
Eliquis	Apixaban	398	99
Tramadol Hcl	Tramadol Hcl	368	76
Metformin Hcl	Metformin Hcl	331	96
Gabapentin	Gabapentin	327	75
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	322	64
Pantoprazole Sodium	Pantoprazole Sodium	294	83
Tamsulosin Hcl	Tamsulosin Hcl	268	72
Pravastatin Sodium	Pravastatin Sodium	251	74
Potassium Chloride	Potassium Chloride	234	74
Sertraline Hcl	Sertraline Hcl	224	56
Furosemide	Furosemide	213	71
Irbesartan	Irbesartan	202	53
Hydrochlorothiazide	Hydrochlorothiazide	200	61
Jardiance	Empagliflozin	182	42
Simvastatin	Simvastatin	182	45
Trazodone Hcl	Trazodone Hcl	182	52
Valsartan	Valsartan	182	53
Alprazolam	Alprazolam	173	45
Allopurinol	Allopurinol	172	50
Spironolactone	Spironolactone	160	53
Albuterol Sulfate Hfa	Albuterol Sulfate	152	57
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	144	36
Pregabalin	Pregabalin	143	32
Trulicity	Dulaglutide	130	25
Metformin Hcl Er	Metformin Hcl	128	41
Fluticasone Propionate	Fluticasone Propionate	124	40
Clopidogrel	Clopidogrel Bisulfate	121	36
Duloxetine Hcl	Duloxetine Hcl	118	29
Lovastatin	Lovastatin	114	30
Escitalopram Oxalate	Escitalopram Oxalate	112	34
Lorazepam	Lorazepam	112	25
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	112	30
Prednisone	Prednisone	110	53
Zolpidem Tartrate	Zolpidem Tartrate	103	18
Warfarin Sodium	Warfarin Sodium	100	28
Famotidine	Famotidine	95	27
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	95	27
Glimepiride	Glimepiride	92	29
Citalopram Hbr	Citalopram Hydrobromide	89	23
Metoprolol Tartrate	Metoprolol Tartrate	87	25
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	83	23
Buspirone Hcl	Buspirone Hcl	80	29
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	79	22
Mounjaro	Tirzepatide	76	19
Azithromycin	Azithromycin	74	56
Farxiga	Dapagliflozin Propanediol	73	18
Atenolol	Atenolol	71	21
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	69	20
Ozempic	Semaglutide	67	21
Donepezil Hcl	Donepezil Hcl	62	14
Spiriva Respimat	Tiotropium Bromide	59	15
Acetaminophen-Codeine	Acetaminophen With Codeine	57	14
Alendronate Sodium	Alendronate Sodium	55	15
Cephalexin	Cephalexin	53	38
Finasteride	Finasteride	53	14
Montelukast Sodium	Montelukast Sodium	53	16
Xarelto	Rivaroxaban	53	17
Ezetimibe	Ezetimibe	52	14
Memantine Hcl	Memantine Hcl	52	13
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	52	suppressed
Baclofen	Baclofen	51	15
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	51	12
Bupropion Xl	Bupropion Hcl	49	17
Fenofibrate	Fenofibrate Nanocrystallized	49	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	49	13
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	49	13
Meloxicam	Meloxicam	48	15
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	48	16
Venlafaxine Hcl Er	Venlafaxine Hcl	48	14
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	47	12
Propranolol Hcl Er	Propranolol Hcl	45	11
Quetiapine Fumarate	Quetiapine Fumarate	44	12
Amitriptyline Hcl	Amitriptyline Hcl	42	12
Estradiol	Estradiol	42	18
Ciprofloxacin Hcl	Ciprofloxacin Hcl	41	34
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	41	17
Novolog Flexpen	Insulin Aspart	41	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	39	suppressed
Bumetanide	Bumetanide	39	13
Meclizine Hcl	Meclizine Hcl	39	14
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	39	15
Chlorthalidone	Chlorthalidone	38	12
Clonazepam	Clonazepam	38	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	38	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	37	suppressed
Tizanidine Hcl	Tizanidine Hcl	37	12
Ibuprofen	Ibuprofen	35	12
Amiodarone Hcl	Amiodarone Hcl	34	11
Bupropion Hcl Sr	Bupropion Hcl	34	11
Primidone	Primidone	34	suppressed
Torsemide	Torsemide	34	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	34	12
Telmisartan	Telmisartan	33	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	32	suppressed
Azelastine Hcl	Azelastine Hcl	32	14
Celecoxib	Celecoxib	31	12
Ipratropium Bromide	Ipratropium Bromide	29	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	29	11
Risperidone	Risperidone	29	suppressed
Ventolin Hfa	Albuterol Sulfate	29	suppressed
Diazepam	Diazepam	28	suppressed
Myrbetriq	Mirabegron	28	suppressed
Hydralazine Hcl	Hydralazine Hcl	27	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	27	22
Isosorbide Mononitrate Er	Isosorbide Mononitrate	26	suppressed
Synthroid	Levothyroxine Sodium	26	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	25	suppressed
Enalapril Maleate	Enalapril Maleate	25	suppressed
Humalog Kwikpen U-100	Insulin Lispro	25	suppressed
Insulin Syringe	Syringe And Needle,insulin,1ml	25	suppressed
Klor-Con M20	Potassium Chloride	25	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	24	suppressed
Ammonium Lactate	Ammonium Lactate	24	13
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	24	19
Ondansetron Hcl	Ondansetron Hcl	24	20
Paxlovid	Nirmatrelvir/Ritonavir	24	24
Symbicort	Budesonide/Formoterol Fumarate	24	suppressed
Topiramate	Topiramate	24	suppressed
Entresto	Sacubitril/Valsartan	23	suppressed
Felodipine Er	Felodipine	23	suppressed
Fluconazole	Fluconazole	23	14
Paroxetine Hcl	Paroxetine Hcl	23	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	23	15
Januvia	Sitagliptin Phosphate	22	suppressed
Fenofibrate	Fenofibrate	21	suppressed
Lansoprazole	Lansoprazole	21	suppressed
Spiriva Handihaler	Tiotropium Bromide	21	suppressed
Valacyclovir	Valacyclovir Hcl	21	15
Eszopiclone	Eszopiclone	20	suppressed
Latanoprost	Latanoprost	20	suppressed
Ondansetron Odt	Ondansetron	20	suppressed
Hydrocortisone	Hydrocortisone	19	suppressed
Mirtazapine	Mirtazapine	19	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	19	suppressed
Verapamil Er	Verapamil Hcl	19	suppressed
Dulera	Mometasone/Formoterol	18	suppressed
Glipizide Er	Glipizide	18	suppressed
Methocarbamol	Methocarbamol	18	suppressed
Rivastigmine	Rivastigmine Tartrate	18	suppressed
Amoxicillin	Amoxicillin	17	11
Esomeprazole Magnesium	Esomeprazole Magnesium	17	suppressed
Tiotropium Bromide	Tiotropium Bromide	17	suppressed
Zolpidem Tartrate Er	Zolpidem Tartrate	17	suppressed
Benzonatate	Benzonatate	16	15
Diclofenac Sodium	Diclofenac Sodium	16	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	16	14
Humulin 70-30	Insulin Nph Hum/Reg Insulin Hm	16	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	16	suppressed
Acyclovir	Acyclovir	15	suppressed
Digoxin	Digoxin	15	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	15	suppressed
Lactulose	Lactulose	15	suppressed
Nystatin-Triamcinolone	Nystatin/Triamcinolone Acet	15	11
Ramipril	Ramipril	15	suppressed
Trospium Chloride	Trospium Chloride	15	suppressed
Breo Ellipta	Fluticasone/Vilanterol	14	suppressed
Diltiazem 12hr Er	Diltiazem Hcl	14	suppressed
Isosorbide Dinitrate	Isosorbide Dinitrate	14	suppressed
Midodrine Hcl	Midodrine Hcl	14	suppressed
Prazosin Hcl	Prazosin Hcl	14	suppressed
Repatha Sureclick	Evolocumab	14	suppressed
Varenicline Tartrate	Varenicline Tartrate	14	suppressed
Carbidopa-Levodopa Er	Carbidopa/Levodopa	13	suppressed
Nitroglycerin	Nitroglycerin	13	12
Novolog	Insulin Aspart	13	suppressed
Nystatin	Nystatin	13	suppressed
Breyna	Budesonide/Formoterol Fumarate	12	suppressed
Brilinta	Ticagrelor	12	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	12	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	12	suppressed
Clonidine Hcl	Clonidine Hcl	12	suppressed
Colchicine	Colchicine	12	suppressed
Entacapone	Entacapone	12	suppressed
Fluticasone Propionate Hfa	Fluticasone Propionate	12	suppressed
Insulin Lispro	Insulin Lispro	12	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	12	suppressed
Morphine Sulfate Er	Morphine Sulfate	12	suppressed
Qvar Redihaler	Beclomethasone Dipropionate	12	suppressed
Ropinirole Hcl	Ropinirole Hcl	12	suppressed
Solifenacin Succinate	Solifenacin Succinate	12	suppressed
Diltiazem Hcl	Diltiazem Hcl	11	suppressed
Fenofibrate	Fenofibrate,micronized	11	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	11	suppressed
Temazepam	Temazepam	11	suppressed
Terazosin Hcl	Terazosin Hcl	11	suppressed
Xifaxan	Rifaximin	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	$18.85 · 1 records	Boehringer Ingelheim Pharmaceuticals, Inc.	JARDIANCE	1	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

What role, if any, does Jardiance play in your treatment recommendations for me?
How do you evaluate evidence when you have a financial relationship with Boehringer Ingelheim Pharmaceuticals, Inc.?
Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error